| 평가-타쎄바정100mg(염산엘로티닙, Erlotinib hydrochloride(as Erlotinib 100mg)):여드름성발진,가려움-가능함(possible) |
| | | | | 100mg(염산엘로티닙, Erlotinib hydrochloride(as Erlotinib 100mg)):여드름성발진,가려움-가능함(possible)
약품 표준코드: 645000480
훼로바-유서방정(건조황산제일철, ferrous sulfate dried 256mg):여드름성발진,가려움-가능성 적음(unlikely)
약품 표준코드: 642202450
메디락디에스장용캅셀(바실루스서브틸리스균스트렙토코카스페시움균배양물, bacillus subtilis·streptococcus faecium):여드름성발진-가능성 적음(unlikely)
약품 표준코드: 643500900
파자임95이중정(pancreatin 40 mg,simethicone70mg(장용), simethicone25mg(위용)):여드름성발진-가능성 적음(unlikely)
약품 표준코드: 642202290
큐란정(라니티딘염산염, ranitidine HCl(as ranitidine) 150mg):여드름성발진-가능성 적음(unlikely)
약품 표준코드: 642902200
|
|
|
